Pharmaleaders TV
You are here:  / Breaking News / Business / Trending / World news / Regulatory hurdles for Indian Pharma Companies!

Regulatory hurdles for Indian Pharma Companies!

girl-with-microscope-1024x384

Faced with bans on some of its key drugmakers and intellectual property fights with Big Pharma, India has seen the worst pharma export numbers in a decade and a half.

New government numbers show that drug exports were up just 1.2% to $14.84 billion in the year ending March 31, the Economic Times reports. That is the slowest growth in at least 15 years, it said. Given the regulatory head winds blowing against the industry, a government report says the industry’s sales target of $25 billion for the 2012-2013 year does not look achievable.

In the course of the past year, drug products from two Wockhardt plants were banned by the FDA and at least one other plant was banned by the EU. Wockhardt reported that it would lose $100 million in sales just in the U.S. because of the import alerts. The FDA also banned plants belonging to Ranbaxy Laboratories, India’s largest generics maker, as well as one owned by Sun Pharmaceuticals. Ranbaxy already had two plants banned. The long-running regulatory problems at Ranbaxy finally led Japan’s Daiichi Sankyo, which owns controlling interest, to agree to sell the company to Sun Pharma for $3.2 billion.

The report also anticipates a slowing because of challenges to India’s patent process, which has been highly criticized by Western drugmakers that believe it has deprived them of legitimate sales in the country. The industry has urged the U.S. to impose trade sanctions against India if it doesn’t tighten up its processes. It has been particularly critical of its compulsory license law, which can force branded drugmakers to turn over technology to Indian companies to allow them to make cheaper versions of drugs that the government believes are essential but cost too much.

PHARMALEADERS

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.

LEAVE A REPLY

Your email address will not be published. Required fields are marked ( required )

November 2017
M T W T F S S
« Aug    
 12345
6789101112
13141516171819
20212223242526
27282930  
Follow us
Contact us

Network 7 Meadia Group

Bangalore Ph: 080 0000 0000 Mail: editor@pharmaleader.tv